[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @FierceBiotech FierceBiotech FierceBiotech posts on X about has been, $bmy, $nvo, gilead sciences the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::18294197/interactions)  - X Week XXXXXX +17% - X Month XXXXXX -XX% - X Months XXXXXXX +22% - X Year XXXXXXX -XXXX% ### Mentions: XX [#](/creator/twitter::18294197/posts_active)  - X Week XX +64% - X Month XX +11% - X Months XXX -XXXX% - X Year XXX +24% ### Followers: XXXXXXX [#](/creator/twitter::18294197/followers)  - X Week XXXXXXX +0.03% - X Month XXXXXXX +0.13% - X Months XXXXXXX +0.59% - X Year XXXXXXX -XXXX% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::18294197/influencer_rank)  ### Social Influence [#](/creator/twitter::18294197/influence) --- **Social category influence** [stocks](/list/stocks) XXXXX% [travel destinations](/list/travel-destinations) XXXX% [finance](/list/finance) XXXX% [technology brands](/list/technology-brands) XXXX% **Social topic influence** [has been](/topic/has-been) 6.25%, [$bmy](/topic/$bmy) #33, [$nvo](/topic/$nvo) 2.08%, [gilead sciences](/topic/gilead-sciences) 2.08%, [sanofi](/topic/sanofi) 2.08%, [prize](/topic/prize) 2.08%, [eli lilly](/topic/eli-lilly) 2.08%, [$lly](/topic/$lly) 2.08%, [$prta](/topic/$prta) 2.08%, [linked](/topic/linked) XXXX% **Top accounts mentioned or mentioned by** [@polaronfinance](/creator/undefined) [@braincures](/creator/undefined) [@truedat999](/creator/undefined) [@_joebaffoe](/creator/undefined) [@pennysunited](/creator/undefined) [@persimmonti](/creator/undefined) [@mateosagan](/creator/undefined) [@dudebiotech](/creator/undefined) [@cashinsider](/creator/undefined) [@biotechanalysst](/creator/undefined) [@chuminhua432](/creator/undefined) [@agingdoc1](/creator/undefined) [@lineagecell](/creator/undefined) [@baselarea](/creator/undefined) [@eathopepray](/creator/undefined) [@biogerontology](/creator/undefined) [@_mindawilson](/creator/undefined) [@joserestonva](/creator/undefined) [@acfer12](/creator/undefined) [@stonkmasterj](/creator/undefined) **Top assets mentioned** [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Novo-Nordisk (NVO)](/topic/$nvo) [Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences) [Sanofi (SNY)](/topic/sanofi) [Eli Lilly and Company (LLY)](/topic/eli-lilly) [Prothena Corporation plc Ordinary Shares (PRTA)](/topic/$prta) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Denali Therapeutics Inc. Common Stock (DNLI)](/topic/$dnli) ### Top Social Posts [#](/creator/twitter::18294197/posts) --- Top posts by engagements in the last XX hours "Bristol Myers Squibb hasagreed to pay $XXX billion to buy Orbital Therapeutics for a pipeline led by a preclinical CD19 autoimmune program" [X Link](https://x.com/FierceBiotech/status/1976656692688638061) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-10T14:30Z 101.7K followers, 3703 engagements "After Omeros hit pause on developing its MASP-3 inhibitor zaltenibart Novo Nordisk is offering up to $XXX billion to scoop the rare disease drug. $NVO" [X Link](https://x.com/FierceBiotech/status/1978469419543404687) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-15T14:34Z 101.7K followers, 1986 engagements "Gilead Sciences and Arcus Biosciences anti-TIGIT antibody domvanalimab has been tied to median overall survival of close to XX months keeping alive one of the last remaining hopes for this once-hyped modality" [X Link](https://x.com/FierceBiotech/status/1977804038227075253) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-13T18:30Z 101.7K followers, 3714 engagements "Kailera Therapeutics has pulled in one of the largest private fundraises of the year raising $XXX million to take its lead obesity program into phase 3" [X Link](https://x.com/FierceBiotech/status/1978099206280696211) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-14T14:02Z 101.7K followers, 2432 engagements "The FDA hashanded out the first nine national priority vouchers positioning companies including Merck KGaA Regeneron and Sanofi to complete the approval process in one to two months" [X Link](https://x.com/FierceBiotech/status/1979184792613556610) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-17T13:56Z 101.7K followers, 1833 engagements "Bristol Myers Squibb is pointing to a XX% overall response rate from one cohort of an early-stage study of its EGFRxHER3 ADC as evidence the pharma can stay ahead of the competition. $BMY" [X Link](https://x.com/FierceBiotech/status/1979199040689434886) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-17T14:53Z 101.7K followers, 2530 engagements "The 2025 Nobel Prize in Physiology or Medicine has been awarded to three pioneering immunologists for their work on regulatory T cells including two who conducted their winning work at a British biotech" [X Link](https://x.com/FierceBiotech/status/1975187595257622752) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-06T13:13Z 101.7K followers, 2641 engagements "Lilly shared oral GLP-1 data from two of the remaining three trials in its diabetes program racking up wins against placebo and AstraZenecas Farxiga. $LLY" [X Link](https://x.com/FierceBiotech/status/1978476406213410869) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-15T15:01Z 101.7K followers, 1741 engagements "An early clinical studyhas linked Prothenas anti-amyloid beta antibody to a higher rate of brain swelling than rival approved drugs hindering the biotechs positioning in early symptomatic Alzheimers disease. $PRTA" [X Link](https://x.com/FierceBiotech/status/1961050309276393626) [@FierceBiotech](/creator/x/FierceBiotech) 2025-08-28T12:56Z 101.7K followers, 2747 engagements "Less than two years after breaking ground on a $XXX billion R&D center and future U.K. headquarters in London Merck & Co. is bailing on the project and discontinuing all research operations in Britain citing an unwelcoming business environment. $MRK" [X Link](https://x.com/FierceBiotech/status/1965867708618305956) [@FierceBiotech](/creator/x/FierceBiotech) 2025-09-10T19:59Z 101.7K followers, 77.3K engagements "Ono Pharmaceuticals EP4 antagonist hit the primary progression-free survival endpoint in a phase X trial in patients with gastric cancer" [X Link](https://x.com/FierceBiotech/status/1976299616715899372) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-09T14:52Z 101.7K followers, 3998 engagements "Expedition Therapeutics is gearing up for a phase X trek with a $XXX million series A" [X Link](https://x.com/FierceBiotech/status/1976345699488076217) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-09T17:55Z 101.7K followers, 2201 engagements "Pushing deeper into in vivo cell therapies BMS hasagreed to pay $XXX billion to buy Orbital Therapeutics for a pipeline led by a preclinical CD19 autoimmune program. $BMY" [X Link](https://x.com/FierceBiotech/status/1976668392540270912) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-10T15:17Z 101.7K followers, 2192 engagements "The FDA has delayed an approval decision for Denali's enzyme replacement therapy designed to treat a rare genetic disorder called Hunter syndrome. The decision has been pushed back three months to April X. $DNLI" [X Link](https://x.com/FierceBiotech/status/1978080088273965337) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-14T12:46Z 101.7K followers, 2296 engagements "Dianthus is offering Leads Biolabs up to $X billion biobucks for licensing rights to a 'pipeline in a product' bispecific antibody designed to treat certain autoimmune disorders. $DNTH" [X Link](https://x.com/FierceBiotech/status/1978845664990703920) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-16T15:29Z 101.7K followers, 1838 engagements "A regulatory impasse and the FDAs cancellation of a meeting to discuss the next steps in a R&D program have prompted Kezar Life Sciences to lay off staff and explore strategic alternatives. $KZR" [X Link](https://x.com/FierceBiotech/status/1979173632132690421) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-17T13:12Z 101.7K followers, 1752 engagements "Big day for biotech newsFierce Biotech has you covered with the largest stories of the morning below: X. ESMO: BMS looks to 'stay ahead of the competition' with ADC's XX% response rate in early-stage trial X. FDA names nine first recipients of 1- to 2-month priority review vouchers X. Licensing galore: Roche Chugai and Kite strike up deals and" [X Link](https://x.com/FierceBiotech/status/1979215247622787219) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-17T15:57Z 101.7K followers, 3141 engagements "Two ex-Moderna leaders have hit a milestone in their new endeavor closing a $XXX million inaugural fund for their biotech venture capital firm called Ascenta" [X Link](https://x.com/FierceBiotech/status/1976374532576509956) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-09T19:49Z 101.7K followers, 2937 engagements "4. Astellas walks away from gene therapy pact with Taysha before pivotal trial launch X. I-Mab undergoes makeover with new name strategy asset and Hong Kong IPO plans" [X Link](https://x.com/FierceBiotech/status/1979216372455403855) [@FierceBiotech](/creator/x/FierceBiotech) 2025-10-17T16:02Z 101.7K followers, 1516 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@FierceBiotech FierceBiotech
FierceBiotech posts on X about has been, $bmy, $nvo, gilead sciences the most. They currently have XXXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXXX +17%
- X Month XXXXXX -XX%
- X Months XXXXXXX +22%
- X Year XXXXXXX -XXXX%
Mentions: XX #
- X Week XX +64%
- X Month XX +11%
- X Months XXX -XXXX%
- X Year XXX +24%
Followers: XXXXXXX #
- X Week XXXXXXX +0.03%
- X Month XXXXXXX +0.13%
- X Months XXXXXXX +0.59%
- X Year XXXXXXX -XXXX%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXXX% travel destinations XXXX% finance XXXX% technology brands XXXX%
Social topic influence has been 6.25%, $bmy #33, $nvo 2.08%, gilead sciences 2.08%, sanofi 2.08%, prize 2.08%, eli lilly 2.08%, $lly 2.08%, $prta 2.08%, linked XXXX%
Top accounts mentioned or mentioned by @polaronfinance @braincures @truedat999 @_joebaffoe @pennysunited @persimmonti @mateosagan @dudebiotech @cashinsider @biotechanalysst @chuminhua432 @agingdoc1 @lineagecell @baselarea @eathopepray @biogerontology @_mindawilson @joserestonva @acfer12 @stonkmasterj
Top assets mentioned Bristol-Myers Squibb Co (BMY) Novo-Nordisk (NVO) Gilead Sciences, Inc. (GILD) Sanofi (SNY) Eli Lilly and Company (LLY) Prothena Corporation plc Ordinary Shares (PRTA) Merck & Co., Inc. (MRK) Denali Therapeutics Inc. Common Stock (DNLI)
Top Social Posts #
Top posts by engagements in the last XX hours
"Bristol Myers Squibb hasagreed to pay $XXX billion to buy Orbital Therapeutics for a pipeline led by a preclinical CD19 autoimmune program"
X Link @FierceBiotech 2025-10-10T14:30Z 101.7K followers, 3703 engagements
"After Omeros hit pause on developing its MASP-3 inhibitor zaltenibart Novo Nordisk is offering up to $XXX billion to scoop the rare disease drug. $NVO"
X Link @FierceBiotech 2025-10-15T14:34Z 101.7K followers, 1986 engagements
"Gilead Sciences and Arcus Biosciences anti-TIGIT antibody domvanalimab has been tied to median overall survival of close to XX months keeping alive one of the last remaining hopes for this once-hyped modality"
X Link @FierceBiotech 2025-10-13T18:30Z 101.7K followers, 3714 engagements
"Kailera Therapeutics has pulled in one of the largest private fundraises of the year raising $XXX million to take its lead obesity program into phase 3"
X Link @FierceBiotech 2025-10-14T14:02Z 101.7K followers, 2432 engagements
"The FDA hashanded out the first nine national priority vouchers positioning companies including Merck KGaA Regeneron and Sanofi to complete the approval process in one to two months"
X Link @FierceBiotech 2025-10-17T13:56Z 101.7K followers, 1833 engagements
"Bristol Myers Squibb is pointing to a XX% overall response rate from one cohort of an early-stage study of its EGFRxHER3 ADC as evidence the pharma can stay ahead of the competition. $BMY"
X Link @FierceBiotech 2025-10-17T14:53Z 101.7K followers, 2530 engagements
"The 2025 Nobel Prize in Physiology or Medicine has been awarded to three pioneering immunologists for their work on regulatory T cells including two who conducted their winning work at a British biotech"
X Link @FierceBiotech 2025-10-06T13:13Z 101.7K followers, 2641 engagements
"Lilly shared oral GLP-1 data from two of the remaining three trials in its diabetes program racking up wins against placebo and AstraZenecas Farxiga. $LLY"
X Link @FierceBiotech 2025-10-15T15:01Z 101.7K followers, 1741 engagements
"An early clinical studyhas linked Prothenas anti-amyloid beta antibody to a higher rate of brain swelling than rival approved drugs hindering the biotechs positioning in early symptomatic Alzheimers disease. $PRTA"
X Link @FierceBiotech 2025-08-28T12:56Z 101.7K followers, 2747 engagements
"Less than two years after breaking ground on a $XXX billion R&D center and future U.K. headquarters in London Merck & Co. is bailing on the project and discontinuing all research operations in Britain citing an unwelcoming business environment. $MRK"
X Link @FierceBiotech 2025-09-10T19:59Z 101.7K followers, 77.3K engagements
"Ono Pharmaceuticals EP4 antagonist hit the primary progression-free survival endpoint in a phase X trial in patients with gastric cancer"
X Link @FierceBiotech 2025-10-09T14:52Z 101.7K followers, 3998 engagements
"Expedition Therapeutics is gearing up for a phase X trek with a $XXX million series A"
X Link @FierceBiotech 2025-10-09T17:55Z 101.7K followers, 2201 engagements
"Pushing deeper into in vivo cell therapies BMS hasagreed to pay $XXX billion to buy Orbital Therapeutics for a pipeline led by a preclinical CD19 autoimmune program. $BMY"
X Link @FierceBiotech 2025-10-10T15:17Z 101.7K followers, 2192 engagements
"The FDA has delayed an approval decision for Denali's enzyme replacement therapy designed to treat a rare genetic disorder called Hunter syndrome. The decision has been pushed back three months to April X. $DNLI"
X Link @FierceBiotech 2025-10-14T12:46Z 101.7K followers, 2296 engagements
"Dianthus is offering Leads Biolabs up to $X billion biobucks for licensing rights to a 'pipeline in a product' bispecific antibody designed to treat certain autoimmune disorders. $DNTH"
X Link @FierceBiotech 2025-10-16T15:29Z 101.7K followers, 1838 engagements
"A regulatory impasse and the FDAs cancellation of a meeting to discuss the next steps in a R&D program have prompted Kezar Life Sciences to lay off staff and explore strategic alternatives. $KZR"
X Link @FierceBiotech 2025-10-17T13:12Z 101.7K followers, 1752 engagements
"Big day for biotech newsFierce Biotech has you covered with the largest stories of the morning below: X. ESMO: BMS looks to 'stay ahead of the competition' with ADC's XX% response rate in early-stage trial X. FDA names nine first recipients of 1- to 2-month priority review vouchers X. Licensing galore: Roche Chugai and Kite strike up deals and"
X Link @FierceBiotech 2025-10-17T15:57Z 101.7K followers, 3141 engagements
"Two ex-Moderna leaders have hit a milestone in their new endeavor closing a $XXX million inaugural fund for their biotech venture capital firm called Ascenta"
X Link @FierceBiotech 2025-10-09T19:49Z 101.7K followers, 2937 engagements
"4. Astellas walks away from gene therapy pact with Taysha before pivotal trial launch X. I-Mab undergoes makeover with new name strategy asset and Hong Kong IPO plans"
X Link @FierceBiotech 2025-10-17T16:02Z 101.7K followers, 1516 engagements